Overview
Couchbase, Inc., headquartered in the United States, operates primarily within the technology sector, focusing on the development of database technology. The company is renowned for its comprehensive offerings in the database management system (DBMS) arena, including its flagship project, the Couchbase Server, which is an open-source, NoSQL, multi-model, document-oriented database optimized for interactive applications. Couchbase's technologies are engineered to support global application deployments with high-volume data needs, offering robust scalability, flexibility, and consistent high performance. This enables enterprises across various industries to enhance their digital innovation efficiently. The company's solutions cater to big data needs by supporting large-scale cloud deployments and providing real-time analytics.
Basic Stats
The share price of Couchbase, Inc. as of September 5, 2025 is $24.44 / share. This is an increase of 0.21% from the prior week. The market cap (or net worth) of Couchbase, Inc. as of September 5, 2025 is $1,337.04 MM.
The Factor Analysis chart (below right) shows a view of Couchbase, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 1,337.04 MM |
| EV | 1,292.93 MM |
| Shares Out. | 54.71 MM |
| Earnings Date | |
| EPS (TTM) | -1.38 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.49 |
| Short Shares Avail. | 0.45 MM |
| Short Interest | 3.11 MM |
| Short Float | 7.29 % |
| Days to Cover | 4.90 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 51.80 % |
| Volatility (1 yr) | 0.57 |
| Beta | 1.37 |
| Sharpe Ratio (1 yr) | 0.84 |
| Sortino Ratio (1 yr) | 1.46 |
| PE Ratio | -17.77 |
| Price/Book | 10.78 |
| Price/TBV | 10.78 |
| Book/Market | 0.09 |
| EBIT/EV | -0.06 |
| EBIT(3yr avg)/EV | -0.06 |
| ROA | -0.32 |
| ROE | -0.59 |
| ROIC | -0.57 |
| CROIC | -0.14 |
| OCROIC | -0.17 |
| Implied Volatility | 10.82 % |
| Put/Call OI Ratio | 0.27 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Couchbase, Inc. is $23.67. The forecasts range from a low of $19.19 to a high of $27.30. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Couchbase, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-27 | Guggenheim | Buy | Initiate | |
| 2023-01-10 | Barclays | Overweight | Maintains | |
| 2022-12-15 | Wedbush | Neutral | Initiate | |
| 2022-12-07 | RBC Capital | Outperform | Maintains | |
| 2022-12-07 | Goldman Sachs | Neutral | Maintains | |
| 2022-12-07 | Barclays | Overweight | Maintains | |
| 2022-11-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-11-18 | Barclays | Overweight | Maintains | |
| 2022-10-18 | Barclays | Overweight | Maintains | |
| 2022-09-08 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-09-08 | Barclays | Overweight | Maintains | |
| 2022-09-08 | Baird | Outperform | Maintains | |
| 2022-08-16 | Barclays | Overweight | Maintains | |
| 2022-06-15 | DA Davidson | Buy | Initiate | |
| 2022-06-10 | Baird | Outperform | Maintains | |
| 2022-06-09 | Stifel | Buy | Maintains | |
| 2022-06-09 | Oppenheimer | Outperform | Maintains | |
| 2022-06-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-06-09 | Goldman Sachs | Neutral | Maintains | |
| 2022-06-06 | RBC Capital | Outperform | Maintains | |
| 2022-05-20 | Barclays | Overweight | Maintains | |
| 2022-05-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-04-14 | Goldman Sachs | Neutral | Maintains | |
| 2022-03-10 | Stifel | Buy | Maintains | |
| 2022-03-10 | RBC Capital | Outperform | Maintains | |
| 2022-03-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-03-10 | Barclays | Overweight | Maintains | |
| 2022-02-23 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-01-12 | Barclays | Overweight | Maintains | |
| 2021-12-09 | Goldman Sachs | Neutral | Maintains | |
| 2021-12-08 | Oppenheimer | Outperform | Maintains | |
| 2021-12-08 | Goldman Sachs | Neutral | Maintains | |
| 2021-12-08 | Barclays | Overweight | Maintains | |
| 2021-09-09 | Oppenheimer | Outperform | Maintains | |
| 2021-09-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-09-09 | Barclays | Overweight | Maintains | |
| 2021-08-16 | William Blair | Outperform | Initiate | |
| 2021-08-16 | Stifel | Buy | Initiate | |
| 2021-08-16 | RBC Capital | Outperform | Initiate | |
| 2021-08-16 | Morgan Stanley | Equal-Weight | Initiate | |
| 2021-08-16 | Goldman Sachs | Neutral | Initiate | |
| 2021-08-16 | Barclays | Overweight | Initiate | |
| 2021-08-16 | Baird | Outperform | Initiate | |
| 2023-02-15 | Barclays | Overweight | Maintains | |
| 2023-03-08 | Stifel | Buy | Maintains | |
| 2023-03-08 | Guggenheim | Buy | Reiterate | |
| 2023-03-08 | Baird | Outperform | Maintains | |
| 2023-03-08 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-03-08 | RBC Capital | Outperform | Maintains | |
| 2023-06-05 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-06-07 | Barclays | Overweight | Overweight | Maintains |
| 2023-06-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-06-07 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2023-06-07 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-06-07 | Wedbush | Neutral | Neutral | Reiterate |
| 2023-06-07 | Baird | Outperform | Outperform | Maintains |
| 2023-06-07 | Stifel | Buy | Buy | Maintains |
| 2023-12-11 | Barclays | Overweight | Overweight | Maintains |
| 2023-09-13 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-08-18 | Barclays | Overweight | Overweight | Maintains |
| 2023-12-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-12-07 | Stifel | Buy | Buy | Maintains |
| 2023-12-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-09-07 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-03-06 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-03-06 | DA Davidson | Buy | Buy | Maintains |
| 2024-03-06 | Baird | Outperform | Outperform | Maintains |
| 2023-12-14 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-03-06 | Stifel | Buy | Buy | Maintains |
| 2024-03-06 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-03-06 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-03-06 | Guggenheim | Buy | Buy | Maintains |
| 2024-03-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-03-05 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-06-06 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-06-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-06-06 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2024-06-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-06-06 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-06-06 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-06-06 | Baird | Outperform | Outperform | Maintains |
| 2024-02-20 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2024-01-12 | Barclays | Overweight | Overweight | Maintains |
| 2024-05-22 | UBS | Neutral | Initiate | |
| 2024-03-07 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-06-07 | DA Davidson | Buy | Buy | Maintains |
| 2024-06-26 | Needham | Buy | Initiate | |
| 2024-06-25 | Guggenheim | Buy | Buy | Reiterate |
| 2025-06-04 | Rosenblatt | Buy | Buy | Maintains |
| 2025-06-04 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-06-04 | Needham | Buy | Buy | Reiterate |
| 2025-06-24 | Stifel | Buy | Hold | Downgrade |
| 2024-12-12 | Truist Securities | Buy | Initiate | |
| 2025-04-23 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-11-15 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-16 | Piper Sandler | Overweight | Initiate | |
| 2024-10-07 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2024-12-04 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-02-27 | Goldman Sachs | Sell | Sell | Maintains |
| 2024-09-05 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-08-19 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-12-04 | DA Davidson | Buy | Buy | Maintains |
| 2024-12-04 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-12-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-12-04 | Stifel | Buy | Buy | Maintains |
| 2024-12-04 | Guggenheim | Buy | Buy | Reiterate |
| 2024-12-04 | Baird | Outperform | Outperform | Maintains |
| 2024-12-04 | Needham | Buy | Buy | Maintains |
| 2025-04-16 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-09 | Rosenblatt | Buy | Initiate | |
| 2024-09-05 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-09-05 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-09-05 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-09-05 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-09-05 | DA Davidson | Buy | Buy | Maintains |
| 2024-09-05 | UBS | Neutral | Neutral | Maintains |
| 2024-09-05 | Baird | Outperform | Outperform | Maintains |
| 2024-09-05 | Stifel | Buy | Buy | Maintains |
| 2024-09-05 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-09-05 | Needham | Buy | Buy | Reiterate |
| 2025-02-26 | Barclays | Overweight | Overweight | Maintains |
| 2025-02-26 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-26 | Guggenheim | Buy | Buy | Maintains |
| 2025-02-26 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-02-26 | UBS | Neutral | Neutral | Maintains |
| 2025-02-26 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-02-26 | Needham | Buy | Buy | Reiterate |
| 2025-02-26 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-06-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-06-04 | Baird | Outperform | Outperform | Maintains |
| 2025-06-04 | UBS | Neutral | Neutral | Maintains |
| 2025-06-04 | RBC Capital | Outperform | Outperform | Reiterate |
| 2025-06-20 | Needham | Buy | Hold | Downgrade |
| 2025-06-20 | DA Davidson | Buy | Neutral | Downgrade |
| 2025-06-20 | William Blair | Outperform | Market Perform | Downgrade |
| 2025-06-20 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2025-06-20 | Barclays | Overweight | Overweight | Maintains |
| 2025-06-20 | Rosenblatt | Buy | Neutral | Downgrade |
| 2025-06-20 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2025-06-02 | Rosenblatt | Buy | Buy | Maintains |
| 2025-06-23 | Baird | Outperform | Neutral | Downgrade |
| 2025-06-23 | Truist Securities | Buy | Hold | Downgrade |
| 2025-09-05 | Guggenheim | Buy | Neutral | Downgrade |
| 2025-09-05 | UBS | Neutral | Neutral | Maintains |
